These benefits, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the principle of targeting ACKR3 as a novel approach to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-linked disorders. According to accessible science the https://willab162ulb7.blogvivi.com/profile